1. Home
  2. SON vs KNSA Comparison

SON vs KNSA Comparison

Compare SON & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$57.84

Market Cap

5.6B

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$78.10

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
KNSA
Founded
1899
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.9B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
SON
KNSA
Price
$57.84
$78.10
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$60.13
$60.86
AVG Volume (30 Days)
1.2M
686.4K
Earning Date
04-21-2026
04-28-2026
Dividend Yield
4.39%
N/A
EPS Growth
510.30
225.00
EPS
0.68
0.27
Revenue
$7,518,753,000.00
$677,564,000.00
Revenue This Year
$0.10
$37.48
Revenue Next Year
$1.82
$17.87
P/E Ratio
$84.65
$285.48
Revenue Growth
41.72
60.09
52 Week Low
$38.65
$32.69
52 Week High
$60.67
$82.94

Technical Indicators

Market Signals
Indicator
SON
KNSA
Relative Strength Index (RSI) 55.01 65.81
Support Level $55.38 $40.06
Resistance Level $58.08 $82.94
Average True Range (ATR) 1.74 3.75
MACD -0.15 0.20
Stochastic Oscillator 44.82 76.67

Price Performance

Historical Comparison
SON
KNSA

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: